UniProt P11212
P11212
P11212 (UniProt P11212): 12 experimental structures on GenesisL1. Binding sites, pockets, druggability and 3D structures in GL1X.
- UniProt
- P11212
- Experimental structures
- 12
- Predicted models
- 0
Structures
12 records of P11212 in the MolNFT archive: 12 experimental, 0 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 1FZJ | MHC class I natural mutant H-2KBM1 heavy chain complexed with beta-2 microglobulin and vesicular… | x-ray diffraction | P | — | — |
| 1FZJ | MHC class I natural mutant H-2KBM1 heavy chain complexed with beta-2 microglobulin and vesicular… | x-ray diffraction | P | — | — |
| 1FZM | MHC class I natural mutant H-2KBM8 heavy chain complexed with beta-2 microglobulin and vesicular… | x-ray diffraction | P | — | — |
| 1FZM | MHC class I natural mutant H-2KBM8 heavy chain complexed with beta-2 microglobulin and vesicular… | x-ray diffraction | P | — | — |
| 1KBG | MHC Class I H-2KB Presented Glycopeptide RGY8-6H-GAL2 | x-ray diffraction | P | — | — |
| 1KBG | MHC class I H-2KB presented glycopeptide RGY8-6H-GAL2 | x-ray diffraction | P | — | — |
| 1NAM | Murine alloreactive scfv TCR-peptide-MHC class I molecule complex | x-ray diffraction | P | — | — |
| 1NAM | Murine alloreactive scfv TCR-peptide-MHC class I molecule complex | x-ray diffraction | P | — | — |
| 2MHA | Crystal structure of the major histocompatibility complex class I H-2KB molecule containing a… | x-ray diffraction | E, F | — | — |
| 2MHA | Crystal structure of the major histocompatibility complex class I H- 2KB molecule containing a… | x-ray diffraction | E, F | — | — |
| 2VAA | MHC class I H-2KB heavy chain complexed with beta-2 microglobulin and vesicular stomatitis virus… | x-ray diffraction | P | — | — |
| 2VAA | MHC class I H-2KB heavy chain complexed with beta-2 microglobulin and vesicular stomatitis virus… | x-ray diffraction | P | — | — |
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.